Immunology and Microbiology
Human Immunodeficiency Virus
83%
Human Immunodeficiency Virus 1
40%
Vaccine Efficacy
19%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Vaccination Policy
15%
T Cell
13%
Monospecific Antibody
13%
Prevalence
12%
COVID-19
11%
Interferon Type I
11%
Blood Plasma
11%
Mouse
10%
Immune Response
10%
CD4 Lymphocyte Count
10%
Viral Disease
9%
Toxoplasma gondii
9%
T-Helper Cell
9%
Toxoplasmosis
8%
Human Immunodeficiency Virus Infection
8%
Viral Load
7%
Hepatitis C
7%
CD4
7%
Agonist
6%
Macrophage
6%
Innate Immune System
6%
TLR9
6%
Neutralizing Antibody
6%
Helminth
6%
Immunodeficiency
6%
Encephalitis
5%
Infectious Disease
5%
Chlamydia Pneumoniae
5%
Comorbidity
5%
B Cell
5%
Monocyte
5%
Cytotoxic T-Cell
5%
Hepatitis C Virus
5%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Infection
45%
Cohort Analysis
34%
Severe Acute Respiratory Syndrome Coronavirus 2
21%
COVID-19
20%
Antiretroviral Therapy
20%
Disease
20%
Prevalence
16%
Symptom
14%
Diagnosis
12%
Cross Sectional Study
10%
Human Immunodeficiency Virus Infection
8%
Antibiotics
7%
Tuberculosis
6%
Chronic Hepatitis C
6%
Population
6%
Lung Tuberculosis
5%
Cystic Fibrosis
5%
Clinical Trial
5%
Antibiotic Therapy
5%
Hepatitis C Virus
5%
Antivirus Agent
5%
Hepatitis B Virus
5%
Highly Active Antiretroviral Therapy
5%
Health Care
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
72%
Infection
31%
Cohort Study
31%
Disease
25%
Prevalence
14%
SARS Coronavirus
12%
Antivirus Agent
10%
Coronavirinae
10%
Vaccination Policy
8%
Antibiotics
8%
Symptom
8%
Chronic Hepatitis C
8%
Placebo
7%
Hepatitis C Virus
7%
Human Immunodeficiency Virus Infection
6%
Clinical Trial
6%
Randomized Controlled Trial
5%
Hepatitis C
5%
Microdialysis
5%
Adverse Event
5%
Lung Tuberculosis
5%
Pharmacokinetics
5%